UNSPSC 51451500: Anthelmintic chlorophenols

Anthelmintic drugs made from phenols substituted with one or more chlorine atoms in any position.

UNSPSC 51451500 Anthelmintic chlorophenols is a Class code that shows minimal alignment between its nominal taxonomy category and the actual work state and local governments are soliciting under it. The recent opportunities on record—naloxone and drug deactivation systems procurement (Seminole County, Florida), direct-to-manufacturer prescription programs (Texas HHS), medical and first aid supplies for emergency response (City of Tampa), and generic pharmaceutical and OTC products through cooperative purchasing (Minnesota MMCAP)—reflect pharmaceutical, medical supply, and health-system procurement rather than anthelmintic or chlorophenol product families. The code appears to be receiving state and local tags despite not matching the substantive scope of these solicitations, suggesting either a data-entry error in how opportunities are being classified or a significant mismatch between the taxonomy label and procurement practice.

The issuing bodies span state health agencies (Texas HHS), county health systems (Seminole County), municipal fire and rescue departments (City of Tampa), and multistate cooperative purchasing alliances (Minnesota MMCAP administering partnerships across multiple states including Oregon). Geographic activity appears concentrated in Florida, Texas, and Minnesota. Seminole County released IFB 60459723LAS on June 30, 2026, for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023 (note: date discrepancy in source); the City of Tampa issued IFB 26P00145 on March 25, 2026, for 169 line items of medical and first aid supplies with a March 13, 2026, deadline and an estimated contract value of $700,000, designated as a small local business enterprise set-aside with a 5 percent bid discount. Minnesota MMCAP posted RFP S1070000015802 on January 20, 2026, seeking generic multi-source pharmaceuticals and OTC products through authorized wholesalers, with proposals due March 26, 2026. Given the substantial mismatch between the code name and the opportunities actually posted, pursue activity under this code only if your firm specializes in pharmaceutical or medical-supply distribution to state and local health systems; the code itself does not reliably predict relevant work.